Bausch + Lomb (BLCO) is in focus after two product updates: a discontinued glaucoma eye drop program for BL1107 and the launch of Orphia, an AI-powered digital health platform for eye care providers.

Bausch + Lomb, the global eye health company, and Nicox S.A.(EURONEXT PARIS: COX) today announced that Bausch + Lomb hasinitiated its Phase 3clinical program of latanoprostene bunod (previously known ...

Bausch + Lomb’s ONE by ONE Recycling Program has collected more than 690,000 pounds (approximately 114 million units) of used contact lens, eye care and lens care materials in the U.S. The program ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ...

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 Students can apply for this scholarship by ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

LAVAL, QC / ACCESS Newswire / August 7, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the recipients ...

Bausch Health to Provide Scholarships to 10 Students Living with GI Diseases Students can apply for this scholarship by completing the online application, submitting letters of reference, and writing ...